Comparing the impact of beta-blockers and prostaglandin analogues on ocular surface change in glaucoma patients
The connection between glaucoma and ocular surface disease (OSD) is determined more distinct due to increasing research of these chronic and progressive diseases. The purpose of research – an assessment of an impact of beta-blockers and prostaglandin analogues on ocular surface in glaucoma patients....
Saved in:
Main Authors: | M. M. Pupysheva, O. G. Gusarevich, A. A. Gusarevich, T. L. Poloz |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2020-05-01
|
Series: | Сибирский научный медицинский журнал |
Subjects: | |
Online Access: | https://sibmed.elpub.ru/jour/article/view/377 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse effects of prostaglandin analogues used in ophthalmological practice
by: S. Yu. Kazanova
Published: (2021-06-01) -
The effectiveness of transferring patients with open-angle glaucoma to therapy with a preservative-free fixed combination of a carbonic anhydrase inhibitor and a prostaglandin analogue
by: S. A. Korotkikh, et al.
Published: (2024-10-01) -
PROSTAGLANDINS ANALOGUES DURING CATARACT PHACOEMULSIFICATION ON THE BACKGROUND OF PRIMARY GLAUCOMA
by: I. E. Ioshin, et al.
Published: (2016-11-01) -
New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
by: A. S. Dukhanin, et al.
Published: (2024-06-01) -
The use of prostaglandin analogues before and after phacoemulsification cataract with primary glaucoma
by: I. E. Ioshin, et al.
Published: (2018-10-01)